L. Zhang and Y. Liu, Potential interventions for novel coronavirus in China: A systematic review, J. Med. Virol, vol.2020, pp.479-490

C. Lu, X. Liu, and Z. Jia, 2019-nCoV transmission through the ocular surface must not be ignored, Lancet Lond. Engl, vol.395, p.39, 2020.

K. K. To, .. Tsang, O. T. , .. Chik-yan-yip, C. Chan et al., Consistent detection of 2019 novel coronavirus in saliva, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, 2020.

X. Peng, X. Xu, Y. Li, L. Cheng, X. Zhou et al., Transmission routes of 2019-nCoV and controls in dental practice, Int. J. Oral Sci, vol.12, p.9, 2020.

L. Zou, F. Ruan, M. Huang, L. Liang, H. Huang et al., SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, N. Engl. J. Med, vol.382, pp.1177-1179, 2020.

A. S. Sultan, E. F. Kong, A. M. Rizk, and M. A. Jabra-rizk, The oral microbiome: A Lesson in coexistence, PLoS Pathog, vol.14, p.1006719, 2018.

E. Zaura, E. A. Nicu, B. P. Krom, and B. J. Keijser, Acquiring and maintaining a normal oral microbiome: current perspective. Front, Cell. Infect. Microbiol, vol.4, p.85, 2014.

P. N. Deo and R. Deshmukh, Oral microbiome: Unveiling the fundamentals, J. Oral Maxillofac. Pathol. JOMFP, vol.23, pp.122-128, 2019.

Y. Lim, M. Totsika, M. Morrison, and C. Punyadeera, Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers, vol.7, pp.4313-4321, 2017.

A. Lamarre and P. J. Talbot, Effect of pH and temperature on the infectivity of human coronavirus 229E, Can. J. Microbiol, vol.35, pp.972-974, 1989.

C. Geller, M. Varbanov, and R. E. Duval, Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies, Viruses, vol.4, pp.3044-3068, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01650388

A. M. Lynge-pedersen and D. Belstrøm, The role of natural salivary defences in maintaining a healthy oral microbiota, J. Dent, vol.80, issue.1, pp.3-12, 2019.

F. F. Tuon, O. Gavrilko, S. Almeida, and . De,

E. R. Sumi, T. Alberto, J. L. Rocha, and E. A. Rosa, Prospective, randomised, controlled study evaluating early modification of oral microbiota following admission to the intensive care unit and oral hygiene with chlorhexidine, J. Glob. Antimicrob. Resist, vol.8, pp.159-163, 2017.

Z. Khatoon, C. D. Mctiernan, E. J. Suuronen, T. Mah, and E. I. Alarcon, Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention, 1067.

T. Mah, Biofilm-specific antibiotic resistance, Future Microbiol, vol.7, pp.1061-1072, 2012.

J. Ruby and J. Barbeau, The buccale puzzle: The symbiotic nature of endogenous infections of the oral cavity. Can, J. Infect. Dis. J. Can. Mal. Infect, vol.13, pp.34-41, 2002.

C. R. Shaler, J. Choi, P. T. Rudak, A. Memarnejadian, P. A. Szabo et al., MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression, PLoS Biol, p.2001930, 2017.

L. Tonoyan, S. Vincent-bugnas, C. Olivieri, and A. Doglio, New Viral Facets in Oral Diseases: The EBV Paradox, Int. J. Mol. Sci, p.5861, 1920.

R. A. Giacaman, A. C. Asrani, K. H. Gebhard, E. A. Dietrich, A. Vacharaksa et al., Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells, Retrovirology, vol.5, p.29, 2008.

F. Carrouel, S. Viennot, L. Ottolenghi, C. Gaillard, and D. Bourgeois, Nanoparticles as Anti-Microbial, Anti-Inflammatory, and Remineralizing Agents in Oral Care Cosmetics: A Review of the Current Situation, Nanomater. Basel Switz, vol.10, p.140, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02448042

T. Blom, D. E. Slot, M. Quirynen, and G. A. Van-der-weijden, The effect of mouthrinses on oral malodor: a systematic review, Int. J. Dent. Hyg, vol.10, pp.209-222, 2012.

S. Takenaka, T. Ohsumi, and Y. Noiri, Evidence-based strategy for dental biofilms: Current evidence of mouthwashes on dental biofilm and gingivitis, Jpn. Dent. Sci. Rev, vol.55, pp.33-40, 2019.

J. Messika, B. La-combe, and J. Ricard, Oropharyngeal colonization: epidemiology, treatment and ventilator-associated pneumonia prevention, Ann. Transl. Med, vol.6, p.426, 2018.

A. M. Milstone, C. L. Passaretti, and T. M. Perl, Chlorhexidine: expanding the armamentarium for infection control and prevention, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.46, pp.274-281, 2008.

F. Hua, H. Xie, H. V. Worthington, S. Furness, Q. Zhang et al., Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia, Cochrane Database Syst. Rev, vol.10, p.8367, 2016.

S. J. Gartenmann, I. Dörig, P. Sahrmann, U. Held, C. Walter et al., Influence of different postinterventional maintenance concepts on periodontal outcomes: an evaluation of three systematic reviews, BMC Oral Health, vol.17, p.19, 2016.

S. Shapiro, E. Giertsen, and B. Guggenheim, An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses, Caries Res, vol.36, pp.93-100, 2002.

C. J. Seneviratne, K. C. Leung, .. Wong, C. Lee, S. Li et al., Nanoparticle-Encapsulated Chlorhexidine against Oral Bacterial Biofilms, PLOS ONE, vol.9, p.103234, 2014.

A. N. Panche, A. D. Diwan, and S. R. Chandra, Flavonoids: an overview, J. Nutr. Sci, vol.5, p.47, 2016.

E. Middleton, C. Kandaswami, and T. C. Theoharides, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, pp.673-751, 2000.

M. P. Nair, S. Mahajan, J. L. Reynolds, R. Aalinkeel, H. Nair et al., The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system, Clin. Vaccine Immunol. CVI, vol.13, pp.319-328, 2006.

H. P. Kim, K. H. Son, H. W. Chang, and S. S. Kang, Anti-inflammatory plant flavonoids and cellular action mechanisms, J. Pharmacol. Sci, vol.96, pp.229-245, 2004.

L. G. Korkina, Afanas'ev, I.B. Antioxidant and chelating properties of flavonoids, Adv. Pharmacol. San Diego Calif, vol.38, pp.151-163, 1997.

B. Q. Li, T. Fu, Y. Dongyan, J. A. Mikovits, F. W. Ruscetti et al., Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry, Biochem. Biophys. Res. Commun, vol.276, pp.534-538, 2000.

J. F. Shimizu, C. S. Lima, C. M. Pereira, C. Bittar, M. N. Batista et al., Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus Entry. Sci. Rep. 2017, vol.7, p.16127

S. Jo, H. Kim, S. Kim, D. H. Shin, and M. Kim, Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors, Chem. Biol. Drug Des, vol.94, pp.2023-2030, 2019.

Y. B. Ryu, H. J. Jeong, J. H. Kim, Y. M. Kim, J. Park et al., Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition, Bioorg. Med. Chem, vol.18, pp.7940-7947, 2010.

I. Saliasi, J. C. Llodra, M. Bravo, P. Tramini, C. Dussart et al., Effect of a Toothpaste/Mouthwash Containing Carica papaya Leaf Extract on Interdental Gingival Bleeding: A Randomized Controlled Trial, Int. J. Environ. Res. Public. Health, p.2660, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02308082

L. Karygianni, A. Al-ahmad, A. Argyropoulou, E. Hellwig, A. C. Anderson et al., Natural Antimicrobials and Oral Microorganisms: A Systematic Review on Herbal Interventions for the Eradication of, Multispecies Oral Biofilms. Front. Microbiol, vol.6, p.1529, 2015.

S. J. Hooper, M. A. Lewis, M. J. Wilson, and D. W. Williams, Antimicrobial activity of Citrox bioflavonoid preparations against oral microorganisms, Br. Dent. J, 2011.

S. Malic, C. Emanuel, M. Lewis, and D. Williams, Antimicrobial activity of novel mouthrinses against planktonic cells and biofilms of pathogenic microorganisms, Microbiol. Discov, 2011.

S. S. Jambhekar and P. Breen, Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex, Drug Discov. Today, vol.21, pp.356-362, 2016.

P. Saokham, C. Muankaew, P. Jansook, and T. Loftsson, Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes. Mol. Basel Switz, vol.23, p.1161, 2018.

S. S. Jambhekar and P. Breen, Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency, Drug Discov. Today, vol.21, pp.363-368, 2016.

, Questions and answers on cyclodextrins used as excipients in medicinal products for human use, p.10, 2020.

S. V. Kurkov, T. Loftsson, and . Cyclodextrins, Int. J. Pharm, vol.453, pp.167-180, 2013.

T. Irie and K. Uekama, Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation, J. Pharm. Sci, vol.86, pp.147-162, 1997.

G. Tiwari, R. Tiwari, and A. K. Rai, Cyclodextrins in delivery systems: Applications, J. Pharm. Bioallied Sci, vol.2, pp.72-79, 2010.

T. Loftsson, P. Jarho, M. Másson, and T. Järvinen, Cyclodextrins in drug delivery, Expert Opin. Drug Deliv, vol.2, pp.335-351, 2005.

S. S. Braga and . Cyclodextrins, Emerging Medicines of the New Millennium. Biomolecules, vol.9, p.801, 2019.

A. Pratelli and V. Colao, Role of the lipid rafts in the life cycle of canine coronavirus, J. Gen. Virol, vol.96, pp.331-337, 2015.

T. Kusakabe, K. Ozasa, S. Kobari, M. Momota, N. Kishishita et al., Intranasal hydroxypropyl-?-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection, vol.34, pp.3191-3198, 2016.

M. Onishi, K. Ozasa, K. Kobiyama, K. Ohata, M. Kitano et al., Hydroxypropyl-?-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen, J. Immunol. Baltim. Md, vol.194, pp.2673-2682, 1950.

L. Leclercq, Interactions between cyclodextrins and cellular components: Towards greener medical applications?, Beilstein J. Org. Chem, vol.12, pp.2644-2662, 2016.

S. T. Jones, V. Cagno, M. Jane?ek, D. Ortiz, N. Gasilova et al., Modified cyclodextrins as broad-spectrum antivirals, Sci. Adv, vol.6, p.9318, 2020.

G. Varan, C. Varan, N. Erdo?ar, A. A. H?ncal, and E. Bilensoy, Amphiphilic cyclodextrin nanoparticles, Int. J. Pharm, vol.531, pp.457-469, 2017.

E. Bilensoy and A. A. Hincal, Recent advances and future directions in amphiphilic cyclodextrin nanoparticles, Expert Opin. Drug Deliv, vol.6, pp.1161-1173, 2009.